Charting Alzheimer's Disease and Dementia: Epidemiological Insights, Risk Factors and Prevention Pathways.

Alzheimer’s disease epidemiology prevention public health risk factors

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
13 Jul 2024
Historique:
received: 23 05 2024
revised: 08 07 2024
accepted: 09 07 2024
medline: 27 7 2024
pubmed: 27 7 2024
entrez: 27 7 2024
Statut: epublish

Résumé

Alzheimer's disease (AD), the most common cause of dementia, is a complex and multifactorial condition without cure at present. The latest treatments, based on anti-amyloid monoclonal antibodies, have only a modest effect in reducing the progression of cognitive decline in AD, whereas the possibility of preventing AD has become a crucial area of research. In fact, recent studies have observed a decrease in dementia incidence in developed regions such as the US and Europe. However, these trends have not been mirrored in non-Western countries (Japan or China), and the contributing factors of this reduction remain unclear. The Lancet Commission has delineated a constrained classification of 12 risk factors across different life stages. Nevertheless, the scientific literature has pointed to over 200 factors-including sociodemographic, medical, psychological, and sociocultural conditions-related to the development of dementia/AD. This narrative review aims to synthesize the risk/protective factors of dementia/AD. Essentially, we found that risk/protective factors vary between individuals and populations, complicating the creation of a unified prevention strategy. Moreover, dementia/AD explanatory mechanisms involve a diverse array of genetic and environmental factors that interact from the early stages of life. In the future, studies across different population-based cohorts are essential to validate risk/protective factors of dementia. This evidence would help develop public health policies to decrease the incidence of dementia.

Identifiants

pubmed: 39064140
pii: jcm13144100
doi: 10.3390/jcm13144100
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Israel Contador (I)

Department of Basic Psychology, Psychobiology, and Methodology of Behavioral Sciences, Faculty of Psychology, University of Salamanca, 37005 Salamanca, Spain.
Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, 17117 Stockholm, Sweden.

Bárbara Buch-Vicente (B)

Department of Basic Psychology, Psychobiology, and Methodology of Behavioral Sciences, Faculty of Psychology, University of Salamanca, 37005 Salamanca, Spain.

Teodoro Del Ser (T)

Alzheimer Centre Reina Sofia-CIEN Foundation, Institute of Health Carlos III, 28031 Madrid, Spain.

Sara Llamas-Velasco (S)

Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.
Department of Neurology, University Hospital 12 de Octubre, 28041 Madrid, Spain.

Alberto Villarejo-Galende (A)

Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.
Department of Neurology, University Hospital 12 de Octubre, 28041 Madrid, Spain.

Julián Benito-León (J)

Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.
Department of Neurology, University Hospital 12 de Octubre, 28041 Madrid, Spain.
Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28029 Madrid, Spain.
Department of Medicine, Faculty of Medicine, Complutense University, 28040 Madrid, Spain.

Félix Bermejo-Pareja (F)

Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28029 Madrid, Spain.
Department of Medicine, Faculty of Medicine, Complutense University, 28040 Madrid, Spain.

Classifications MeSH